
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Emerging SARS-CoV-2 variants expand species tropism to murines
Huiping Shuai, Jasper Fuk‐Woo Chan, Terrence Tsz‐Tai Yuen, et al.
EBioMedicine (2021) Vol. 73, pp. 103643-103643
Open Access | Times Cited: 168
Huiping Shuai, Jasper Fuk‐Woo Chan, Terrence Tsz‐Tai Yuen, et al.
EBioMedicine (2021) Vol. 73, pp. 103643-103643
Open Access | Times Cited: 168
Showing 1-25 of 168 citing articles:
Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shift
Elisabetta Cameroni, John E. Bowen, Laura E. Rosen, et al.
Nature (2021) Vol. 602, Iss. 7898, pp. 664-670
Open Access | Times Cited: 1106
Elisabetta Cameroni, John E. Bowen, Laura E. Rosen, et al.
Nature (2021) Vol. 602, Iss. 7898, pp. 664-670
Open Access | Times Cited: 1106
Attenuated replication and pathogenicity of SARS-CoV-2 B.1.1.529 Omicron
Huiping Shuai, Jasper Fuk‐Woo Chan, Bingjie Hu, et al.
Nature (2022) Vol. 603, Iss. 7902, pp. 693-699
Open Access | Times Cited: 608
Huiping Shuai, Jasper Fuk‐Woo Chan, Bingjie Hu, et al.
Nature (2022) Vol. 603, Iss. 7902, pp. 693-699
Open Access | Times Cited: 608
Structural basis of SARS-CoV-2 Omicron immune evasion and receptor engagement
Matthew McCallum, Nadine Czudnochowski, Laura E. Rosen, et al.
Science (2022) Vol. 375, Iss. 6583, pp. 864-868
Open Access | Times Cited: 501
Matthew McCallum, Nadine Czudnochowski, Laura E. Rosen, et al.
Science (2022) Vol. 375, Iss. 6583, pp. 864-868
Open Access | Times Cited: 501
SARS-CoV-2 Omicron variant shows less efficient replication and fusion activity when compared with Delta variant in TMPRSS2-expressed cells
Hanjun Zhao, Lu Lu, Peng Zheng, et al.
Emerging Microbes & Infections (2021) Vol. 11, Iss. 1, pp. 277-283
Open Access | Times Cited: 385
Hanjun Zhao, Lu Lu, Peng Zheng, et al.
Emerging Microbes & Infections (2021) Vol. 11, Iss. 1, pp. 277-283
Open Access | Times Cited: 385
Omicron: What Makes the Latest SARS-CoV-2 Variant of Concern So Concerning?
Christoph Jung, Dorota Kmieć, Lennart Koepke, et al.
Journal of Virology (2022) Vol. 96, Iss. 6
Open Access | Times Cited: 203
Christoph Jung, Dorota Kmieć, Lennart Koepke, et al.
Journal of Virology (2022) Vol. 96, Iss. 6
Open Access | Times Cited: 203
Limited cross-variant immunity from SARS-CoV-2 Omicron without vaccination
Rahul K. Suryawanshi, Irene P. Chen, Tongcui Ma, et al.
Nature (2022) Vol. 607, Iss. 7918, pp. 351-355
Open Access | Times Cited: 181
Rahul K. Suryawanshi, Irene P. Chen, Tongcui Ma, et al.
Nature (2022) Vol. 607, Iss. 7918, pp. 351-355
Open Access | Times Cited: 181
Divergent SARS-CoV-2 variant emerges in white-tailed deer with deer-to-human transmission
Bradley Pickering, Oliver Lung, Finlay Maguire, et al.
Nature Microbiology (2022) Vol. 7, Iss. 12, pp. 2011-2024
Open Access | Times Cited: 181
Bradley Pickering, Oliver Lung, Finlay Maguire, et al.
Nature Microbiology (2022) Vol. 7, Iss. 12, pp. 2011-2024
Open Access | Times Cited: 181
Transmission of SARS-CoV-2 from humans to animals and potential host adaptation
Cedric C.S. Tan, Su Datt Lam, Damien Richard, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 120
Cedric C.S. Tan, Su Datt Lam, Damien Richard, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 120
Molecular characteristics, immune evasion, and impact of SARS-CoV-2 variants
Cong Sun, Chu Xie, Guo‐Long Bu, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 113
Cong Sun, Chu Xie, Guo‐Long Bu, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 113
Immune response in COVID-19: what is next?
Qing Li, Ying Wang, Qiang Sun, et al.
Cell Death and Differentiation (2022) Vol. 29, Iss. 6, pp. 1107-1122
Open Access | Times Cited: 110
Qing Li, Ying Wang, Qiang Sun, et al.
Cell Death and Differentiation (2022) Vol. 29, Iss. 6, pp. 1107-1122
Open Access | Times Cited: 110
Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shift
Elisabetta Cameroni, John E. Bowen, Laura E. Rosen, et al.
Nature (2021)
Open Access | Times Cited: 107
Elisabetta Cameroni, John E. Bowen, Laura E. Rosen, et al.
Nature (2021)
Open Access | Times Cited: 107
Origin and evolutionary analysis of the SARS-CoV-2 Omicron variant
Yamin Sun, Wenchao Lin, Wei Dong, et al.
Journal of Biosafety and Biosecurity (2021) Vol. 4, Iss. 1, pp. 33-37
Open Access | Times Cited: 107
Yamin Sun, Wenchao Lin, Wei Dong, et al.
Journal of Biosafety and Biosecurity (2021) Vol. 4, Iss. 1, pp. 33-37
Open Access | Times Cited: 107
Accelerating antiviral drug discovery: lessons from COVID-19
Annette von Delft, Matthew D. Hall, Ann D. Kwong, et al.
Nature Reviews Drug Discovery (2023) Vol. 22, Iss. 7, pp. 585-603
Open Access | Times Cited: 94
Annette von Delft, Matthew D. Hall, Ann D. Kwong, et al.
Nature Reviews Drug Discovery (2023) Vol. 22, Iss. 7, pp. 585-603
Open Access | Times Cited: 94
Omicron variant (B.1.1.529) and its sublineages: What do we know so far amid the emergence of recombinant variants of SARS-CoV-2?
Manish Dhawan, AbdulRahman A. Saied, Saikat Mitra, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 154, pp. 113522-113522
Open Access | Times Cited: 93
Manish Dhawan, AbdulRahman A. Saied, Saikat Mitra, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 154, pp. 113522-113522
Open Access | Times Cited: 93
Animal models in SARS-CoV-2 research
Hin Chu, Jasper Fuk‐Woo Chan, Kwok‐Yung Yuen
Nature Methods (2022) Vol. 19, Iss. 4, pp. 392-394
Open Access | Times Cited: 88
Hin Chu, Jasper Fuk‐Woo Chan, Kwok‐Yung Yuen
Nature Methods (2022) Vol. 19, Iss. 4, pp. 392-394
Open Access | Times Cited: 88
An orally available Mpro inhibitor is effective against wild-type SARS-CoV-2 and variants including Omicron
Baoxue Quan, Huiping Shuai, Anjie Xia, et al.
Nature Microbiology (2022) Vol. 7, Iss. 5, pp. 716-725
Open Access | Times Cited: 80
Baoxue Quan, Huiping Shuai, Anjie Xia, et al.
Nature Microbiology (2022) Vol. 7, Iss. 5, pp. 716-725
Open Access | Times Cited: 80
Essential role of TMPRSS2 in SARS-CoV-2 infection in murine airways
Naoko Iwata‐Yoshikawa, Masatoshi Kakizaki, Nozomi Shiwa-Sudo, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 80
Naoko Iwata‐Yoshikawa, Masatoshi Kakizaki, Nozomi Shiwa-Sudo, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 80
Spike mutations contributing to the altered entry preference of SARS-CoV-2 omicron BA.1 and BA.2
Bingjie Hu, Jasper Fuk‐Woo Chan, Huan Liu, et al.
Emerging Microbes & Infections (2022) Vol. 11, Iss. 1, pp. 2275-2287
Open Access | Times Cited: 68
Bingjie Hu, Jasper Fuk‐Woo Chan, Huan Liu, et al.
Emerging Microbes & Infections (2022) Vol. 11, Iss. 1, pp. 2275-2287
Open Access | Times Cited: 68
A new generation Mpro inhibitor with potent activity against SARS-CoV-2 Omicron variants
Chong Huang, Huiping Shuai, Jingxin Qiao, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 49
Chong Huang, Huiping Shuai, Jingxin Qiao, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 49
Nasally delivered interferon-λ protects mice against infection by SARS-CoV-2 variants including Omicron
Zhenlu Chong, Courtney E. Karl, Peter Halfmann, et al.
Cell Reports (2022) Vol. 39, Iss. 6, pp. 110799-110799
Open Access | Times Cited: 63
Zhenlu Chong, Courtney E. Karl, Peter Halfmann, et al.
Cell Reports (2022) Vol. 39, Iss. 6, pp. 110799-110799
Open Access | Times Cited: 63
Highly divergent white-tailed deer SARS-CoV-2 with potential deer-to-human transmission
Bradley Pickering, Oliver Lung, Finlay Maguire, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 62
Bradley Pickering, Oliver Lung, Finlay Maguire, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 62
Heterogeneous Infectivity and Pathogenesis of SARS-CoV-2 Variants Beta, Delta and Omicron in Transgenic K18-hACE2 and Wildtype Mice
Ferran Tarrés-Freixas, Benjamin Trinité, Anna Pons-Grífols, et al.
Frontiers in Microbiology (2022) Vol. 13
Open Access | Times Cited: 57
Ferran Tarrés-Freixas, Benjamin Trinité, Anna Pons-Grífols, et al.
Frontiers in Microbiology (2022) Vol. 13
Open Access | Times Cited: 57
Coronaviruses exploit a host cysteine-aspartic protease for replication
Hin Chu, Yuxin Hou, Dong Yang, et al.
Nature (2022)
Closed Access | Times Cited: 57
Hin Chu, Yuxin Hou, Dong Yang, et al.
Nature (2022)
Closed Access | Times Cited: 57
Co-circulation of two SARS-CoV-2 variant strains within imported pet hamsters in Hong Kong
Kin‐Hang Kok, Shuk‐Ching Wong, Wan-Mui Chan, et al.
Emerging Microbes & Infections (2022) Vol. 11, Iss. 1, pp. 689-698
Open Access | Times Cited: 50
Kin‐Hang Kok, Shuk‐Ching Wong, Wan-Mui Chan, et al.
Emerging Microbes & Infections (2022) Vol. 11, Iss. 1, pp. 689-698
Open Access | Times Cited: 50
Age-associated SARS-CoV-2 breakthrough infection and changes in immune response in a mouse model
Yanxia Chen, Can Li, Feifei Liu, et al.
Emerging Microbes & Infections (2022) Vol. 11, Iss. 1, pp. 368-383
Open Access | Times Cited: 41
Yanxia Chen, Can Li, Feifei Liu, et al.
Emerging Microbes & Infections (2022) Vol. 11, Iss. 1, pp. 368-383
Open Access | Times Cited: 41